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Background
Among cell types targeted by HIV-1 are dendritic cells
(DCs), which play a central role in protection against
infections and activation of anti-microbial immune
responses. HIV-1 binds pathogen receptor DC-SIGN
expressed by DCs and is transferred to CD4
+ T-lympho-
cytes. We previously identified BSSL (bile-salt stimulated
lipase) as the DC-SIGN binding and HIV-1 transfer
blocking glycoprotein in human milk. In vitro DC-SIGN
binding properties of human milk associated with a varia-
tion in the number of repeats encoded by exon 11 of the
BSSL gene. BSSL is not only expressed in milk but also in
blood and blood BSSL binds to CXCR4. We hypothesized
that BSSL in blood interferes with the interaction of
CXCR4 and DC-SIGN with HIV-1 and thus influences
HIV-1 infection and HIV-1 disease progression.
Materials and methods
The relation between BSSL exon 11 repeat numbers and
HIV-1 transmission and disease course as well as the
emergence of CXCR4-using variants were studied using
Kaplan Meier and multivariate Cox proportional hazard
analysis. Additionally, the association of BSSL genotype
with CD4 cell count was analyzed, both pre-infection
and post-infection at viral setpoint. The study group
existed of a cohort of men having sex with men and
included 334 seropositive and 48 high risk seronegative
individuals (HRSN) participating in the Amsterdam
Cohort Studies on HIV infection and AIDS.
Results
The number of repeats in BSSL exon 11 were highly vari-
able ranging from 10 to 18 in seropositive individuals
and from 5-17 in HRSN with 16 repeats being dominant
(82% in the seropositive and 85% in the HRSN group
carry at least one allele with 16 repeats). As compared to
seropositives, a trend was observed with HRSN having
more frequently two alleles with 16 repeats (p=0.059).
We then defined 16 to 18 repeats as high (H) and less
than 16 repeats as low (L) repeat numbers. Individuals
have either two low (LL), one low and one high (LH) or
two high repeat number alleles (HH). The HH BSSL gen-
otype associated with high CD4 cell numbers prior to
HIV-1 infection (p=0.007). No differences were found
between BSSL genotypes in CD4 count and virus load at
viral setpoint post seroconversion. However, the HH
BSSL genotype was linked to slow disease progression
(p=0.049, RH=0.737) and delayed emergence of CXCR4-
using HIV-1 variants (p=0.007, RH=0.515).
Conclusion
We identified BSSL as a marker for HIV-1 disease pro-
gression, CXCR4 using HIV-1 variant emergence and
CD4 cell homeostasis. Knowledge on the identified
BSSL genotypes may help develop a new class of thera-
peutic molecules aimed at treating HIV-1 disease.
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